PMC:7652766 / 89115-89345 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T435","span":{"begin":0,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Conversely, Cao et al. (313) conducted a controlled open‐label study with 199 hospitalized severe COVID‐19 patients randomly divided into two groups: a standard care group and a lopinavir/ritonavir treatment group (400 mg/100 mg)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3238","span":{"begin":107,"end":115},"obj":"Species"},{"id":"3240","span":{"begin":176,"end":177},"obj":"Gene"},{"id":"3241","span":{"begin":150,"end":151},"obj":"Gene"},{"id":"3242","span":{"begin":39,"end":40},"obj":"Gene"},{"id":"3243","span":{"begin":178,"end":197},"obj":"Chemical"},{"id":"3247","span":{"begin":98,"end":106},"obj":"Disease"}],"attributes":[{"id":"A3238","pred":"tao:has_database_id","subj":"3238","obj":"Tax:9606"},{"id":"A3240","pred":"tao:has_database_id","subj":"3240","obj":"Gene:351"},{"id":"A3241","pred":"tao:has_database_id","subj":"3241","obj":"Gene:351"},{"id":"A3242","pred":"tao:has_database_id","subj":"3242","obj":"Gene:351"},{"id":"A3243","pred":"tao:has_database_id","subj":"3243","obj":"MESH:C558899"},{"id":"A3247","pred":"tao:has_database_id","subj":"3247","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Conversely, Cao et al. (313) conducted a controlled open‐label study with 199 hospitalized severe COVID‐19 patients randomly divided into two groups: a standard care group and a lopinavir/ritonavir treatment group (400 mg/100 mg)."}